Ensysce Biosciences

ENSCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.646 M

$0.34 -7.60%

Close of 6 Nov 2026

As of 6 Nov 2026, Ensysce Biosciences (ENSC) has a market capitalization of $6.65M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$5.07M

#3259 by revenue

Earnings

-$10.2M

Loss-making

Shares outstanding

19,456,794

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#436MetaViaMTVA$6.92M
#437ImmuronIMRN$6.70M
#438Ensysce BiosciencesENSC$6.65M
#439Kiora PharmaceuticalsKPRX$6.64M
#440FibroBiologicsFBLG$6.36M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Ensysce Biosciences, worth $444.2K. Grants and option exercises are excluded.

Bob G. Gower$444.2K
908,614 shares at $0.49 on 23 Apr 2026 · filed 18 Aug 2026

What if Ensysce Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,451,260

Per share 4,248,420× higher

Bitcoin $1.53T

$78,525.17

Per share 229,875× higher

Apple $5.02T

$257,790.80

Per share 754,657× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Ensysce Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.